These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23198563)

  • 21. Helicobacter pylori, pepsinogen, and gastric adenocarcinoma in Hawaii.
    Nomura AM; Kolonel LN; Miki K; Stemmermann GN; Wilkens LR; Goodman MT; Perez-Perez GI; Blaser MJ
    J Infect Dis; 2005 Jun; 191(12):2075-81. PubMed ID: 15897993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Strategies for extermination of gastric cancer from Japan].
    Asaka M
    Nihon Rinsho; 2011 Jan; 69(1):173-82. PubMed ID: 21226280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response of IgG1 and IgG2 subclasses to Helicobacter pylori in subjects with chronic inflammation of the gastric mucosa, atrophy and gastric cancer in a country with high Helicobacter pylori infection prevalence.
    Vorobjova T; Ren Z; Dunkley M; Clancy R; Maaroos HI; Labotkin R; Kull K; Uibo R
    APMIS; 2006 May; 114(5):372-80. PubMed ID: 16725014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential features of gastric cancer patients, either Helicobacter pylori positive or Helicobacter pylori negative.
    Jonkers D; Houben P; Hameeteman W; Stobberingh E; de Bruine A; Arends JW; Biemond I; Lundqvist G; Stockbrügger R
    Ital J Gastroenterol Hepatol; 1999 Dec; 31(9):836-41. PubMed ID: 10669990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of degree of health of the stomach by concomitant measurement of serum pepsinogen and serum Helicobacter pylori antibodies.
    Inoue K; Fujisawa T; Haruma K
    Int J Biol Markers; 2010; 25(4):207-12. PubMed ID: 21161942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of Gastric Neoplasia in Cases Negative for Helicobacter pylori Antibody and with Normal Pepsinogen.
    Kishikawa H; Kimura K; Ito A; Arahata K; Takarabe S; Kaida S; Miyauchi J; Miura S; Nishida J
    Anticancer Res; 2015 Dec; 35(12):6765-71. PubMed ID: 26637894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The non-invasive diagnosis of precancerous changes of stomach mucosa.
    Pasechnikov VD; Chukov SZ; Kotelevets SM; Mostovov AN; Polyakova MB; Mernova VP
    Rocz Akad Med Bialymst; 2004; 49():66-71. PubMed ID: 15631316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Physiopathology of Helicobacter pylori infection: Pepsinogen secretion].
    Urita Y; Miki K
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():235-9. PubMed ID: 11979784
    [No Abstract]   [Full Text] [Related]  

  • 29. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
    Cao Q; Ran ZH; Xiao SD
    J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Follow-up study on a high risk population of gastric cancer in north China by serum pepsinogen assay.
    Sun LP; Gong YH; Wang L; Gong W; Yuan Y
    J Dig Dis; 2008 Feb; 9(1):20-6. PubMed ID: 18251790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
    Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
    Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-parietal cell antibody and serum pepsinogen assessment in screening for gastric carcinoma.
    Sugiu K; Kamada T; Ito M; Kaya S; Tanaka A; Kusunoki H; Hata J; Haruma K
    Dig Liver Dis; 2006 May; 38(5):303-7. PubMed ID: 16549394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum pepsinogen levels, Helicobacter pylori CagA Status, and cytokine gene polymorphisms associated with gastric premalignant lesions in Costa Rica.
    Con SA; Con-Wong R; Con-Chin GR; Con-Chin VG; Takeuchi H; Valerín AL; Echandi G; Mena F; Brenes F; Yasuda N; Araki K; Sugiura T
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2631-6. PubMed ID: 18086767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies to CagA protein are associated with gastric atrophy in Helicobacter pylori infection.
    Beales IL; Crabtree JE; Scunes D; Covacci A; Calam J
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):645-9. PubMed ID: 8853252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human gastric cancer risk screening: From rat pepsinogen studies to the ABC method.
    Furihata C
    Proc Jpn Acad Ser B Phys Biol Sci; 2021; 97(8):462-478. PubMed ID: 34629355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined serum IgG response to Helicobacter pylori VacA and CagA predicts gastric cancer.
    Janulaityte-Günther D; Kupcinskas L; Pavilonis A; Valuckas K; Wadström T; Andersen LP
    FEMS Immunol Med Microbiol; 2007 Jul; 50(2):220-5. PubMed ID: 17567283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinico-pathological study of Helicobacter pylori in early gastric cancer].
    Handa Y; Misaka R; Kawaguchi M; Saitoh T
    Nihon Rinsho; 1993 Dec; 51(12):3249-54. PubMed ID: 8283642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoblotting using multiple antigens is essential to demonstrate the true risk of Helicobacter pylori infection for gastric cancer.
    Mitchell H; English DR; Elliott F; Gengos M; Barrett JH; Giles GG; Forman D
    Aliment Pharmacol Ther; 2008 Oct; 28(7):903-10. PubMed ID: 18624791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between serum pepsinogen A and C levels, serum gastrin concentrations and Helicobacter pylori antibodies.
    Kullich W; Pöllmann G; Czerwenka C; Klein G
    Wien Med Wochenschr; 1999; 149(7):157-61. PubMed ID: 10413837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of gastric cancer development by serum pepsinogen test and Helicobacter pylori seropositivity in Eastern Asians: a systematic review and meta-analysis.
    Terasawa T; Nishida H; Kato K; Miyashiro I; Yoshikawa T; Takaku R; Hamashima C
    PLoS One; 2014; 9(10):e109783. PubMed ID: 25314140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.